Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
07/2003
07/03/2003US20030124150 Kit for reducing aching
07/03/2003US20030124148 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124094 Increasing or maintaining the blood supply in the penis
07/03/2003CA2471400A1 Vaginal delivery of drugs
07/03/2003CA2471355A1 Substituted diketopiperazines as oxytocin antagonists
07/03/2003CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
07/03/2003CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/03/2003CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor
07/02/2003EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322660A2 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds
07/02/2003EP1322651A1 Bicyclic heteroaromatic compounds
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/02/2003EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
07/02/2003EP1322592A1 Substituted 1-aminobutan-3-ol derivatives
07/02/2003EP1322336A1 Method of increasing testosterone and related steroid concentrations in women
07/02/2003EP1322333A2 Composition for combined use of aromatase inhibitors
07/02/2003EP1322315A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
07/02/2003EP1322286A2 Polymeric delivery formulations of leuprolide with improved efficacy
07/02/2003EP1017371B1 Controlled release of drugs delivered by sublingual or buccal administration
07/02/2003EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
07/02/2003CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
07/02/2003CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
07/02/2003CN1427719A Use of substituted acryloyl distamycin derivatives in treatment of tumors associated with high levels of glutathione
07/02/2003CN1426812A Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma
07/02/2003CN1426805A Health care food capable of promoting female breast well developed
07/02/2003CN1426798A Life prolonging and root securing pill and its processing method
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/02/2003CN1112928C Use of CGMP-phosphodiesterase inhibitors to treat impotence
07/01/2003US6586582 Human GABA receptor proteins and polynucleotides encoding the same
07/01/2003US6586569 Endometriosis-associated gene
07/01/2003US6586474 Amidino compounds useful as nitric oxide synthase inhibitors
07/01/2003US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide
07/01/2003US6586439 Pharmaceutically active compounds
07/01/2003US6586436 Serotonergic agents
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
07/01/2003US6586402 Leucine replaced by neopentylglycine or adamantylalanine
07/01/2003US6586391 Method of ameliorating erectile dysfunction
07/01/2003US6585982 Treatment of infertility
06/2003
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051903A1 Androstane derivative having substituent in 7- and 17-positions
06/26/2003WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof
06/26/2003WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof
06/26/2003WO2003051878A1 Quinolinones as prostaglandin receptor ligands
06/26/2003WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
06/26/2003WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
06/26/2003WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS
06/26/2003WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
06/26/2003WO2003051851A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051837A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr)
06/26/2003WO2003051825A1 Human adam-10 inhibitors
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents
06/26/2003WO2003051384A1 Method for treating cervical cancer
06/26/2003WO2003051383A2 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003WO2003051372A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003WO2003051371A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
06/26/2003WO2003051370A1 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
06/26/2003WO2003051369A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds
06/26/2003WO2003051353A1 Substituted beta-aminoalcohols used as medicaments
06/26/2003WO2003051344A1 Methods of inducing ovulation_using a non-polypeptide camp level modulator
06/26/2003WO2003051337A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
06/26/2003WO2003051336A1 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2002046385A3 Enzymes
06/26/2003US20030120224 Feminine care products for the delivery of therapeutic substances
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119800 Administering an ANGELS (Activators of Non-Genotropic Estrogen-like Signaling compound"ANGELS") compound to maintain or increase bone mass, bone density and/or bone strength.
06/26/2003US20030119778 Novel gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030118638 Oral pharmaceutical products containing 17 beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation
06/26/2003US20030118633 Treating unstable or overactive urinary bladder by administering an antimuscarinic agent and an estrogen agonist
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118571 Oral administration of lactobacillus for the maintenance of health in women during pregnancy and at other life stages, to reduce the risk of urogenital diseases
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2746308A1 Method for treating human papilloma virus
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2473877A1 Substituted beta-aminoalcohols as pharmaceutical preparations
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470640A1 Use of hmgb proteins and nucleic acids that code therefor
06/26/2003CA2470624A1 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
06/26/2003CA2470209A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 557